Sera Prognostics, Inc. (SERA)
2.51
-0.06
(-2.33%)
USD |
NASDAQ |
Feb 20, 16:00
2.495
-0.02
(-0.60%)
After-Hours: 20:00
Sera Prognostics Shareholders Equity (Quarterly) : 82.18M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 598.36M |
| Plus Therapeutics, Inc. | 5.054M |
| Atossa Therapeutics, Inc. | 49.79M |
| Abeona Therapeutics, Inc. | 171.23M |
| Cell Source, Inc. | -18.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.12M |
| Total Liabilities (Quarterly) | 25.94M |
| Debt to Equity Ratio | 0.0298 |
| Current Ratio | 1.893 |
| Net Debt Paydown Yield | -0.18% |